Elective Nodal Irradiation for Non-small Cell Lung Cancer Complicated With Chronic Obstructive Pulmonary Disease Affects Immunotherapy Αfter Definitive Chemoradiotherapy
Masahiro Morimoto(The University of Osaka), Teruki Teshima(Osaka International Cancer Institute), Shingo Ohira(Osaka International Cancer Institute), Hanako Kuhara(Osaka International Cancer Institute), Kazumi Nishino(Osaka Medical Center for Cancer and Cardiovascular Diseases), Motohiro Tamiya(Osaka International Cancer Institute), Erina Nakanishi(Osaka International Cancer Institute), Masayasu Toratani(Osaka International Cancer Institute), Fumio Imamura(Osaka International Cancer Institute), Naoyuki Kanayama(Osaka International Cancer Institute), Kika Ohira(Osaka International Cancer Institute), Kentaro Wada, Kei Kunimasa(Kobe University), Hayato Kawachi(Osaka International Cancer Institute), Takashi Matsunaga(Shiga University of Medical Science), Madoka Kimura(Osaka International Cancer Institute), Toru Kumagai(University of Pennsylvania), Takero Hirata(Osaka International Cancer Institute), Koji Konishi(Osaka International Cancer Institute), Tomohiro Sagawa(Osaka International Cancer Institute), Takako Inoue, Masayoshi Miyazaki(Aso Iizuka Hospital)
Cited by 9
Related Papers
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet Oncology|2019|617
Phase III Study, V-15-32, of Gefitinib Versus Docetaxel in Previously Treated Japanese Patients With Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2008|365
Validation of A New Prognostic Staging System for Hepatocellular Carcinoma: the Jis Score Compared With the Clip Score
|Hepatology|2004|359
Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis
|Journal of Gastroenterology|2009|205